Beaumont Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-855
Closed -$223K 290
2019
Q2
$223K Sell
855
-315
-27% -$83.6K 0.02% 227
2019
Q1
$334K Sell
1,170
-375
-24% -$125K 0.04% 176
2018
Q4
$502K Hold
1,545
0.08% 124
2018
Q3
$695K Hold
1,545
0.07% 120
2018
Q2
$632K Sell
1,545
-947
-38% -$343K 0.07% 116
2018
Q1
$725K Sell
2,492
-58
-2% -$14.7K 0.08% 109
2017
Q4
$478K Buy
2,550
+300
+13% +$56K 0.06% 124
2017
Q3
$379K Hold
2,250
0.05% 131
2017
Q2
$322K Buy
2,250
+445
+25% +$59.8K 0.04% 144
2017
Q1
$226K Sell
1,805
-470
-21% -$54.5K 0.03% 170
2016
Q4
$256K Hold
2,275
0.04% 129
2016
Q3
$292K Buy
2,275
+125
+6% +$15K 0.05% 120
2016
Q2
$235K Sell
2,150
-1,850
-46% -$184K 0.04% 126
2016
Q1
$286K Buy
+4,000
New +$338K 0.05% 113
2015
Q2
Sell
-4,000
Closed -$286K 159
2015
Q1
$286K Buy
+4,000
New +$217K 0.01% 133

Other funds holding ABMD

Beaumont Financial Advisors's ABMD Position: Q3 2019 in Review

Beaumont Financial Advisors sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 855 shares — an estimated $223K sold.

Beaumont Financial Advisors first reported a position in ABMD in Q1 2015 and held it in 15 quarters. The position peaked at $725K in Q1 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Beaumont Financial Advisors reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Beaumont Financial Advisors sold 855 Abiomed Inc shares in Q3 2019, an estimated $223K.
  • Beaumont Financial Advisors first reported a position in Abiomed Inc in Q1 2015 and held it in 15 quarters.
  • Beaumont Financial Advisors's Abiomed Inc position peaked at $725K in Q1 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Beaumont Financial Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.